A revolutionary homeopathic treatment by Dr. A.K. Dwivedi gives renewed hope to patients with rare blood disorders like ITP. The case of 7-year-old Ayushmann Singh, whose platelet count dramatically ...

John Elkhay, owner of 10 Prime Steak & Sushi, is opening a new seafood restaurant, Ten Prime Seafood, in downtown Providence.

The report provides a detailed analysis of the current myelodysplastic syndrome marketed drugs and late-stage pipeline drugs.

There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting ...

Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...

During a live event, Thomas LeBlanc, MD, MA, discussed dose escalation of luspatercept in myelodysplastic syndromes and ...

A panelist emphasizes that treatment decisions for anemia in low-risk myelodysplastic syndrome should be guided by symptoms ...

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Drug ...

I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, ...

Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.

The report provides a detailed analysis of the current apraxia marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- According to the latest ...

RYTELO is a first-in-class oligonucleotide telomerase inhibitor that is approved in the US for adult patients with low-to-intermediate-1 risk LR-MDS with transfusion-dependent anemia requiring 4 or ...